Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-18
2010-06-08
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S416000, C514S418000, C514S419000, C514S493000
Reexamination Certificate
active
07732479
ABSTRACT:
Indole derivatives, compositions including same, and methods utilizing same for the treatment of amyloid associated diseases, such as type II diabetes mellitus, Alzheimer's dementia or diseases, systemic and localized amyloidosis, and prion-related encephalopathies are provided.
REFERENCES:
patent: 2920080 (1960-01-01), Bucourt et al.
patent: 3042685 (1962-03-01), Roussel
patent: 3625973 (1971-12-01), Julia
patent: 3790596 (1974-02-01), Shkilkova et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3976639 (1976-08-01), Batcho et al.
patent: 4036945 (1977-07-01), Haber
patent: 4299917 (1981-11-01), Berger et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4626540 (1986-12-01), Capps et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4970233 (1990-11-01), McHugh
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5210215 (1993-05-01), Politi et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5304470 (1994-04-01), Fischer et al.
patent: 5332648 (1994-07-01), Kihara et al.
patent: 5475096 (1995-12-01), Gold et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5556744 (1996-09-01), Weiner et al.
patent: 5567588 (1996-10-01), Gold et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5595877 (1997-01-01), Gold et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5637459 (1997-06-01), Burke et al.
patent: 5643768 (1997-07-01), Kawasaki
patent: 5658754 (1997-08-01), Kawasaki
patent: 5659041 (1997-08-01), Pollak et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5683867 (1997-11-01), Biesecker et al.
patent: 5705337 (1998-01-01), Gold et al.
patent: 5916642 (1999-06-01), Chang
patent: 6162828 (2000-12-01), Fukuda et al.
patent: 6251625 (2001-06-01), Bommarius et al.
patent: 6255286 (2001-07-01), Yanai et al.
patent: 6261569 (2001-07-01), Comis et al.
patent: 6303567 (2001-10-01), Findeis et al.
patent: 6309669 (2001-10-01), Setterstrom et al.
patent: 6326174 (2001-12-01), Joyce et al.
patent: 6359112 (2002-03-01), Kapurniotu et al.
patent: 6361861 (2002-03-01), Gao et al.
patent: 6593339 (2003-07-01), Eek et al.
patent: 6610478 (2003-08-01), Takle et al.
patent: 6613875 (2003-09-01), Ghadiri
patent: 6617114 (2003-09-01), Fowlkes et al.
patent: 6677153 (2004-01-01), Iversen
patent: 6689753 (2004-02-01), Soto-Jara
patent: 6858318 (2005-02-01), Kogiso et al.
patent: 6976639 (2005-12-01), Williams et al.
patent: 7045537 (2006-05-01), Woolfson et al.
patent: 2001/0041732 (2001-11-01), Gurley et al.
patent: 2002/0006954 (2002-01-01), Hensley et al.
patent: 2002/0086067 (2002-07-01), Choi et al.
patent: 2002/0151506 (2002-10-01), Castillo et al.
patent: 2003/0130484 (2003-07-01), Gordon et al.
patent: 2003/0158237 (2003-08-01), Saragovi et al.
patent: 2003/0225155 (2003-12-01), Fernandez-Pol et al.
patent: 2004/0029830 (2004-02-01), Herbert
patent: 2004/0152672 (2004-08-01), Carson et al.
patent: 2005/0069950 (2005-03-01), Haynie
patent: 2006/0079454 (2006-04-01), Reches et al.
patent: 2006/0079455 (2006-04-01), Gazit et al.
patent: 2006/0089380 (2006-04-01), Barnham et al.
patent: 2006/0194777 (2006-08-01), Gazit et al.
patent: 2006/0234947 (2006-10-01), Gazit
patent: 2007/0021345 (2007-01-01), Gazit
patent: 2007/0135334 (2007-06-01), Gazit
patent: 2007/0298043 (2007-12-01), Gazit et al.
patent: 2008/0305040 (2008-12-01), Klunk
patent: 3412445 (1985-10-01), None
patent: 10043282 (2002-03-01), None
patent: 0081122 (1983-06-01), None
patent: 0264166 (1988-04-01), None
patent: 0421946 (1991-04-01), None
patent: 0885904 (2004-03-01), None
patent: 966975 (2005-07-01), None
patent: 59-044313 (1984-03-01), None
patent: 60-040061 (1985-02-01), None
patent: 63-044895 (1988-02-01), None
patent: 02-295923 (1990-06-01), None
patent: 10-245342 (1998-09-01), None
patent: 2000-193661 (2000-07-01), None
patent: WO 80/00789 (1980-01-01), None
patent: WO 92/19253 (1992-11-01), None
patent: WO 97/16191 (1997-09-01), None
patent: WO 98/20135 (1998-05-01), None
patent: WO 99/42102 (1999-08-01), None
patent: WO 99/58652 (1999-11-01), None
patent: WO 00/24390 (2000-04-01), None
patent: WO 01/05421 (2001-01-01), None
patent: WO 01/10457 (2001-02-01), None
patent: WO 01/45726 (2001-06-01), None
patent: WO 01/49307 (2001-07-01), None
patent: WO 01/93836 (2001-12-01), None
patent: WO 02/072086 (2002-09-01), None
patent: WO 02/094857 (2002-11-01), None
patent: WO 03/013442 (2003-02-01), None
patent: WO 03/024443 (2003-03-01), None
patent: WO 03/039540 (2003-05-01), None
patent: WO 03/063760 (2003-07-01), None
patent: WO 03/070269 (2003-08-01), None
patent: WO 03/077866 (2003-09-01), None
patent: WO 2004/052773 (2004-06-01), None
patent: WO 2004/060791 (2004-07-01), None
patent: WO 2005/016339 (2005-02-01), None
patent: WO 2005/020809 (2005-03-01), None
patent: WO 2005/027901 (2005-03-01), None
patent: WO 2005/031362 (2005-04-01), None
patent: WO 2005/085867 (2005-09-01), None
patent: WO 2006/006172 (2006-01-01), None
patent: WO 2006/020681 (2006-02-01), None
patent: WO 2006/027780 (2006-03-01), None
patent: WO 2006/013552 (2006-09-01), None
patent: WO 01/49281 (2007-01-01), None
patent: WO 2007/029003 (2007-03-01), None
patent: WO 2007/043048 (2007-04-01), None
Chyan et al , Journal of Biological Chemistry, vol. 274, No. 31, 21937-21942, 1999.
Alic, p. 1-11, Multiple myeloma, 2002, www.lifesteps.com/gm/Atoz/ency/multiple—myeloma.jsp.
Cherny et al. “The Formation ofEscherichia coliCurli Amyloid Fibrils is Mediated by Prion-Like Peptide Repeats”, Journal of Molecular Biology, 352(2): 245-252, 2005.
Forloni et al. “Anti-Amyloidogenic Activity of Tetracyclines: Studies in Vitro”, FEBS Letters, 487(3): 404-407, 2001. Figs. 1,3.
Ghadiri et al. “Self-Assembling Organic Nanotubes Based on A Cyclic Peptide Architecture”, Nature, 366: 324-327, Dec. 25, 1993.
Görbitz “Nanotube Formation by Hydrophobic Dipeptides”, Chemistry, 7(23): 5153-5159, 2001, Abstract.
Grateau “[Coli's Curli or How Amyloid Can be Physiological.]”, Médecine Sciences, 18(6-7): p. 664, 2002.
Haldar et al. “First Crystallographic Signature of the Highly Ordered Supramolecular Helical Assemblage From A Tripeptide Containing A Non-Coded Amino Acid”, Tetrahedron Letters, 43(14): 2653-2656, 2002. Abstract.
Harrison et al. “Amyloid Peptides and Proteins in Review”, Reviews in Physiology, Biochemistry and Pharmacology, 159: 1-77, 2007.
Hartgerink et al. “Peptide Nanotubes and Beyond”, Chemistry European Journal, 4(8): 1367-1372, 1998. Abstract.
Horne et al. A Heterocyclic Peptide Nanotube, Journal of the American Chemical Society, JACS, 125(31): 9372-9376, Aug. 6, 2003. Abstract.
Lansbury “Following Nature's Anti-Amyloid Strategy”, Nature Biotechnology, 19(2): 112-113, 2001. p. 112, Left-Hand col., § 1—Middle col., § 1.
Maji et al. “Fibril-Forming Model Synthetic Peptides Containing 3-Aminophenylacetic Acid”, Tetrahedron, 58(43): 8695-8702, 2002, Abstract.
Mosselman et al. “The Complete Islet Amyloid Polypeptide Precursor Is Encoded by Two Exons”, FEBS Letters, 247: 154-158, 1989, Database Accession No. S04016.
Nicolaus “Symbiotic Approach to Drug Design”, Decision Making in Drug Research, p. 173-186, 1983.
Reches et al. “Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin”, The Journal of Biological Chemistry, 277(38): 35475-35480, 2002.
Reches et al. “Casting Metal Nanowires Within Discrete Self-Assembled Peptide Nanotubes”, Science, 300(5619): 625-627, 2003, Abstract.
Akazome et al. “Enantioselective Inclusion of Methyl Phenyl Sulfoxides and Benzyl Methyl Sulfoxides by (R)-Phenylglycyl-(R)-Phenylglycine and the Crystal Structures of the Inclusion Cavities”, Journal of Organic Chemistry, 65(1): 68-76, 2000.
Anguiano et al.
Cohen Tomer
Gazit Ehud
Marschel Ardin
Rao Savitha
Tel Aviv University Future Technology Development L.P.
LandOfFree
Compositions for treating amyloid associated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for treating amyloid associated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for treating amyloid associated diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4217542